Molecular genetics of bipolar disorder and depression

Psychiatry and Clinical Neurosciences

Volumn 61, Issue 1, 2007, Pages 3-19

  Kato, Tadafumi ^a  

^a RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

Author keywords

Association study; Bipolar disorder; Linkage study; Major depression; Molecular genetics; Mood disorder

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; ADAPTOR PROTEIN; CADHERIN; CARBAMAZEPINE; CELL ADHESION MOLECULE; DOPAMINE 1 RECEPTOR; FLUVOXAMINE; GUANOSINE TRIPHOSPHATE CYCLOHYDROLASE I; METABOTROPIC RECEPTOR 3; METABOTROPIC RECEPTOR 4; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEU DIFFERENTIATION FACTOR; PROTEIN SERINE THREONINE KINASE; RGS2 PROTEIN; SEROTONIN RECEPTOR; SOMATOSTATIN;

BIPOLAR DISORDER; CHROMOSOME 12Q; CIRCADIAN RHYTHM; CLINICAL FEATURE; COMORBIDITY; DEPRESSION; DNA MICROARRAY; EXTRACHROMOSOMAL INHERITANCE; GASTROINTESTINAL SYMPTOM; GENE EXPRESSION; GENE INTERACTION; GENE LOCUS; GENE MUTATION; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC SELECTION; GENETIC TRAIT; GENOME ANALYSIS; GENOTYPE PHENOTYPE CORRELATION; HAPLOTYPE; HERITABILITY; HETEROZYGOSITY LOSS; HUMAN; LINKAGE ANALYSIS; MOLECULAR GENETICS; MOOD CHANGE; MOOD DISORDER; PEDIGREE; PHARMACOGENETICS; REVIEW; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; SOMATIC DELUSION; STEVENS JOHNSON SYNDROME; TREATMENT RESPONSE;

BIPOLAR DISORDER; DEPRESSIVE DISORDER; HUMANS; MOLECULAR BIOLOGY; PHARMACOGENETICS; SCHIZOPHRENIA;

EID: 33846160926     PISSN: 13231316     EISSN: 14401819     Source Type: Journal    
DOI: 10.1111/j.1440-1819.2007.01604.x     Document Type: Review

References (185)

1. Kato T, Kuratomi G, Kato N. Genetics of bipolar disorder. Drugs Today (Barc.) 2005; 41: 335-344.
2. Berrettini W. Evidence for shared susceptibility in bipolar disorder and schizophrenia. Am. J. Med. Genet. C Semin. Med. Genet. 2003; 123: 59-64.
3. Nievergelt CM, Kripke DF, Barrett TB et al. Suggestive evidence for association of the circadian genes PERIOD3 and ARNTL with bipolar disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2006; 141: 234-241.
4. Cordeiro Q, Talkowski ME, Chowdari KV, Wood J, Nimgaonkar V, Vallada H. Association and linkage analysis of RGS4 polymorphisms with schizophrenia and bipolar disorder in Brazil. Genes Brain Behav. 2005; 4: 45-50.
5. Fallin MD, Lasseter VK, Avramopoulos D et al. Bipolar I disorder and schizophrenia: A 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish case-parent trios. Am. J. Hum. Genet. 2005; 77: 918-936.
6. Thomson PA, Wray NR, Millar JK et al. Association between the TRAX/DISC locus and both bipolar disorder and schizophrenia in the Scottish population. Mol. Psychiatry 2005; 10: 657-668, 616.
7. Papiol S, Rosa A, Gutierrez B et al. Interleukin-1 cluster is associated with genetic risk for schizophrenia and bipolar disorder. J. Med. Genet. 2004; 41: 219-223.
8. Nakatani N, Aburatani H, Nishimura K, Semba J, Yoshikawa T. Comprehensive expression analysis of a rat depression model. Pharmacogenomics J. 2004; 4: 114-126.
9. Koido K, Koks S, Nikopensius T et al. Polymorphisms in wolframin (WFS1) gene are possibly related to increased risk for mood disorders. Int. J. Neuropsychopharmacol. 2005; 8: 235-244.
10. Kato T, Iwayama Y, Kakiuchi C et al. Gene expression and association analyses of LIM (PDLIM5) in bipolar disorder and schizophrenia. Mol. Psychiatry 2005; 10: 1045-1055.
11. Blair IP, Chetcuti AF, Badenhop RF et al. Positional cloning, association analysis and expression studies provide convergent evidence that the cadherin gene FAT contains a bipolar disorder susceptibility allele. Mol. Psychiatry 2006; 11: 372-383.
12. Severino G, Congiu D, Serreli C et al. A48G polymorphism in the D1 receptor genes associated with bipolar I disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2005; 134: 37-38.
13. Dmitrzak-Weglarz M, Rybakowski JK, Slopien A et al. Dopamine receptor D1 gene -48A/G polymorphism is associated with bipolar illness but not with schizophrenia in a Polish population. Neuropsychobiology 2006; 53: 46-50.
14. Green EK, Raybould R, Macgregor S et al. Operation of the schizophrenia susceptibility gene, neuregulin 1, across traditional diagnostic boundaries to increase risk for bipolar disorder. Arch. Gen. Psychiatry 2005; 62: 642-648.
15. Kakiuchi C, Ishiwata M, Nanko S et al. Functional polymorphisms of HSPA5: Possible association with bipolar disorder. Biochem. Biophys. Res. Commun. 2005; 336: 1136-1143.
16. Mansour HA, Wood J, Logue T et al. Association study of eight circadian genes with bipolar I disorder, schizoaffective disorder and schizophrenia. Genes Brain Behav. 2006; 5: 150-157.
17. Arai M, Itokawa M, Yamada K et al. Association of neural cell adhesion molecule 1 gene polymorphisms with bipolar affective disorder in Japanese individuals. Biol. Psychiatry 2004; 55: 804-10.
18. Frank B, Niesler B, Nothen MM et al. Investigation of the human serotonin receptor gene HTR3B in bipolar affective and schizophrenic patients. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2004; 131: 1-5.
19. Glaser B, Kirov G, Green E, Craddock N, Owen MJ. Linkage disequilibrium mapping of bipolar affective disorder at 12q23-q24 provides evidence for association at CUX2 and FLJ32356. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2005; 132: 38-45.
20. Schulze TG, Ohlraun S, Czerski PM et al. Genotype-phenotype studies in bipolar disorder showing association between the DAOA/G30 locus and persecutory delusions: A first step toward a molecular genetic classification of psychiatric phenotypes. Am. J. Psychiatry 2005; 162: 2101-2108.
21. Lyons-Warren A, Chang JJ, Balkissoon R et al. Evidence of association between bipolar disorder and Citron on chromosome 12q24. Mol. Psychiatry 2005; 10: 807-809.
22. Hattori E, Liu C, Badner JA et al. Polymorphisms at the G72/G30 gene locus, on 13q33, are associated with bipolar disorder in two independent pedigree series. Am. J. Hum. Genet. 2003; 72: 1131-1140.
23. Chen YS, Akula N, Detera-Wadleigh SD et al. Findings in an independent sample support an association between bipolar affective disorder and the G72/G30 locus on chromosome 13q33. Mol. Psychiatry 2004; 9: 87-92.
24. Schumacher J, Jamra RA, Freudenberg J et al. Examination of G72 and D-amino-acid oxidase as genetic risk factors for schizophrenia and bipolar affective disorder. Mol. Psychiatry 2004; 9: 203-207.
25. Williams NM, Green EK, Macgregor S et al. Variation at the DAOA/G30 locus influences susceptibility to major mood episodes but not psychosis in schizophrenia and bipolar disorder. Arch. Gen. Psychiatry 2006; 63: 366-373.
26. Kealey C, Roche S, Claffey E, McKeon P. Linkage and candidate gene analysis of 14q22-24 in bipolar disorder: Support for GCHI as a novel susceptibility gene. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2005; 136: 75-80.
27. Otani K, Ujike H, Tanaka Y et al. The GABA type A receptor alpha5 subunit gene is associated with bipolar I disorder. Neurosci. Lett. 2005; 381: 108-113.
28. Meyer J, Johannssen K, Freitag CM et al. Rare variants of the gene encoding the potassium chloride co-transporter 3 are associated with bipolar disorder. Int. J. Neuropsychopharmacol. 2005; 8: 495-504.
29. Weller AE, Dahl JP, Lohoff FW, Ferraro TN, Berrettini WH. Analysis of variations in the NAPG gene on chromosome 18p11 in bipolar disorder. Psychiatr. Genet. 2006; 16: 3-8.
30. McNabb LD, Moore KW, Scena JE, Buono RJ, Berrettini WH. Association analysis of CHMP1.5 genetic variation and bipolar disorder. Psychiatr. Genet. 2005; 15: 211-214.
31. Stopkova P, Saito T, Papolos DF et al. Identification of PIK3C3 promoter variant associated with bipolar disorder and schizophrenia. Biol. Psychiatry 2004; 55: 981-988.
32. Swift-Scanlan T, Coughlin JM, Lan TH et al. Characterization of CTG/CAG repeats on chromosome 18: A study of bipolar disorder. Psychiatr. Genet. 2005; 15: 91-99.
33. Xu C, Macciardi F, Li PP et al. Association of the putative susceptibility gene, transient receptor potential protein melastatin type 2, with bipolar disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2006; 141: 36-43.
34. Hashimoto R, Okada T, Kato T et al. The breakpoint cluster region gene on chromosome 22q11 is associated with bipolar disorder. Biol. Psychiatry 2005; 57: 1097-1102.
35. Verma R, Mukerji M, Grover D et al. MLC1 gene is associated with schizophrenia and bipolar disorder in Southern India. Biol. Psychiatry 2005; 58: 16-22.
36. Verma R, Kubendran S, Das SK, Jain S, Brahmachari SK. SYNGR1 is associated with schizophrenia and bipolar disorder in southern India. J. Hum. Genet. 2005; 50: 635-640.
37. Thomson PA, Wray NR, Thomson AM et al. Sex-specific association between bipolar affective disorder in women and GPR50, an X-linked orphan G protein-coupled receptor. Mol. Psychiatry 2005; 10: 470-478.
38. Munakata K, Tanaka M, Mori K et al. Mitochondrial DNA 3644T→C mutation associated with bipolar disorder. Genomics 2004; 84: 1041-1050.
39. Munakata K, Iwamoto K, Bundo M, Kato T. Mitochondrial DNA 3243A>G mutation and increased expression of LARS2 gene in the brains of patients with bipolar disorder and schizophrenia. Biol. Psychiatry 2005; 57: 525-532.
40. Gregorio SP, Mury FB, Ojopi EB et al. Nogo CAA-3′YTP insertion polymorphism is not associated with schizophrenia nor with bipolar disorder. Schizophr. Res. 2005; 75: 5-9.
41. Lundorf MD, Buttenschon HN, Foldager L et al. Mutational screening and association study of glutamate decarboxylase 1 as a candidate susceptibility gene for bipolar affective disorder and schizophrenia. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2005; 135: 94-101.
42. Leszczynska-Rodziewicz A, Hauser J, Dmitrzak-Weglarz M et al. Lack of association between polymorphisms of dopamine receptors, type D2, and bipolar affective illness in a Polish population. Med. Sci. Monit. 2005; 11: CR289-295.
43. Nishiguchi N, Breen G, Russ C, St Clair D, Collier D. Association analysis of the glycogen synthase kinase-3beta gene in bipolar disorder. Neurosci. Lett. 2006; 394: 243-245.
44. Szczepankiewicz A, Skibinska M, Hauser J et al. Association analysis of the GSK-3beta T-50C gene polymorphism with schizophrenia and bipolar disorder. Neuropsychobiology 2006; 53: 51-56.
45. Lee KY, Ahn YM, Joo EJ et al. No association of two common SNPs at position -1727 A/T -50 C/T of GSK-3 beta polymorphisms with schizophrenia and bipolar disorder of Korean population. Neurosci. Lett. 2006; 395: 175-178.
46. Ide M, Yamada K, Toyota T et al. Genetic association analyses of PHOX2B and ASCL1 in neuropsychiatric disorders: Evidence for association of ASCL1 with Parkinson's disease. Hum. Genet. 2005; 117: 520-527.
47. Abou Jamra R, Schumacher J, Golla A et al. Family-based association studies of alpha-adrenergic receptor genes in chromosomal regions with linkage to bipolar affective disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2004; 126: 79-81.
48. Keikhaee MR, Fadai F, Sargolzaee MR, Javanbakht A, Najmabadi H, Ohadi M. Association analysis of the dopamine transporter (DAT1) -67A/T polymorphism in bipolar disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2005; 135: 47-49.
49. Ambrosio AM, Kennedy JL, Macciardi F et al. A linkage study between the GABAA beta2 and GABAA gamma2 subunit genes and major psychoses. CNS Spectr. 2005; 10: 57-61.
50. Prathikanti S, Schulze TG, Chen YS et al. Neither single-marker nor haplotype analyses support an association between genetic variation near NOTCH4 and bipolar disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2004; 131: 10-15.
51. Raybould R, Green EK, MacGregor S et al. Bipolar disorder and polymorphisms in the dysbindin gene (DTNBP1). Biol. Psychiatry 2005; 57: 696-701.
52. Venken T, Alaerts M, Adolfsson R, Broeckhoven CV, Del-Favero J. No association of the trace amine-associated receptor 6 with bipolar disorder in a northern Swedish population. Psychiatr. Genet. 2006; 16: 1-2.
53. Lohoff FW, Ferraro TN, McNabb L et al. No association between common variations in the neuronal nicotinic acetylcholine receptor alpha2 subunit gene (CHRNA2) and bipolar I disorder. Psychiatry Res. 2005; 135: 171-177.
54. Stopkova P, Vevera J, Paclt I et al. Screening of PIP5K2A promoter region for mutations in bipolar disorder and schizophrenia. Psychiatr. Genet. 2005; 15: 223-227.
55. Kunugi H, Iijima Y, Tatsumi M et al. No association between the Val66Met polymorphism of the brain-derived neurotrophic factor gene and bipolar disorder in a Japanese population: A multicenter study. Biol. Psychiatry 2004; 56: 376-378.
56. Green EK, Raybould R, Macgregor S et al. Genetic variation of brain-derived neurotrophic factor (BDNF) in bipolar disorder: Case-control study of over 3000 individuals from the UK. Br. J. Psychiatry 2006; 188: 21-25.
57. Schumacher J, Jamra RA, Becker T et al. Evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and major depression. Biol. Psychiatry 2005; 58: 307-314.
58. Lai TJ, Wu CY, Tsai HW, Lin YM, Sun HS. Polymorphism screening and haplotype analysis of the tryptophan hydroxylase gene (TPH1) and association with bipolar affective disorder in Taiwan. BMC Med. Genet. 2005; 6: 14.
59. Yamada K, Nakamura K, Minabe Y et al. Association analysis of FEZ1 variants with schizophrenia in Japanese cohorts. Biol. Psychiatry 2004; 56: 683-690.
60. Tadokoro K, Hashimoto R, Tatsumi M, Kamijima K, Kunugi H. Analysis of enhancer activity of a dinucleotide repeat polymorphism in the neurotrophin-3 gene and its association with bipolar disorder. Neuropsychobiology 2004; 50: 206-210.
61. Buttenschon HN, Mors O, Ewald H et al. No association between a neuronal nitric oxide synthase (NOS1) gene polymorphism on chromosome 12q24 and bipolar disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2004; 124: 73-75.
62. Etain B, Rousseva A, Roy I et al. Lack of association between 5HT2A receptor gene haplotype, bipolar disorder and its clinical subtypes in a West European sample. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2004; 129: 29-33.
63. Mansour HA, Talkowski ME, Wood J et al. Serotonin gene polymorphisms and bipolar I disorder: Focus on the serotonin transporter. Ann. Med. 2005; 37: 590-602.
64. Mendlewicz J, Souery D, Del-Favero J et al. Expanded RED products and loci containing CAG/CTG repeats on chromosome 17 (ERDA1) and chromosome 18 (CTG18.1) in trans-generational pairs with bipolar affective disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2004; 128: 71-75.
65. Stopkova P, Vevera J, Paclt I, Zukov I, Lachman HM. Analysis of SYNJ1, a candidate gene for 21q22 linked bipolar disorder: a replication study. Psychiatry Res. 2004; 127: 157-161.
66. Otani K, Ujike H, Tanaka Y et al. The ZDHHC8 gene did not associate with bipolar disorder or schizophrenia. Neurosci. Lett. 2005; 390: 166-170.
67. Cichon S, Buervenich S, Kirov G et al. Lack of support for a genetic association of the XBP1 promoter polymorphism with bipolar disorder in probands of European origin. Nat. Genet. 2004; 36: 783-784; 784-785.
68. Hou SJ, Yen FC, Cheng CY, Tsai SJ, Hong CJ. X-box binding protein 1 (XBP1) C-116G polymorphisms in bipolar disorders and age of onset. Neurosci. Lett. 2004; 367: 232-234.
69. Gutierrez B, Arias B, Gasto C et al. Association analysis between a functional polymorphism in the monoamine oxidase A gene promoter and severe mood disorders. Psychiatr. Genet. 2004; 14: 203-208.
70. Durand CM, Kappeler C, Betancur C et al. Expression and genetic variability of PCDH11Y, a gene specific to Homo sapiens and candidate for susceptibility to psychiatric disorders. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2006; 141: 67-70.
71. Nakatani N, Hattori E, Ohnishi T et al. Genome-wide expression analysis detects eight genes with robust alterations specific to bipolar I disorder: Relevance to neuronal network perturbation. Hum. Mol. Genet. 2006; 15: 1949-1962.
72. Dimitrova A, Milanova V, Krastev S et al. Association study of myo-inositol monophosphatase 2 (IMPA2) polymorphisms with bipolar affective disorder and response to lithium treatment. Pharmacogenomics J. 2005; 5: 35-41.
73. Sjoholt G, Ebstein RP, Lie RT et al. Examination of IMPA1 and IMPA2 genes in manic-depressive patients: Association between IMPA2 promoter polymorphisms and bipolar disorder. Mol. Psychiatry 2004; 9: 621-629.
74. Detera-Wadleigh SD, McMahon FJ. G72/G30 in schizophrenia and bipolar disorder: Review and meta-analysis. Biol. Psychiatry 2006; 60: 106-114.
75. Hashimoto A, Nishikawa T, Hayashi T et al. The presence of free D-serine in rat brain. FEBS Lett. 1992; 296: 33-36.
76. Addington AM, Gornick M, Sporn AL et al. Polymorphisms in the 13q33.2 gene G72/G30 are associated with childhood-onset schizophrenia and psychosis not otherwise specified. Biol. Psychiatry 2004; 55: 976-980.
77. Ferraren DO, Liu C, Badner JA et al. Linkage disequilibrium analysis in the LOC93081-KDELC1-BIVM region on 13q in bipolar disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2005; 133: 12-17.
78. Porteous DJ, Millar JK. Disrupted in schizophrenia 1: Building brains and memories. Trends Mol. Med. 2006; 12: 255-261.
79. Ozeki Y, Tomoda T, Kleiderlein J et al. Disrupted-inschizophrenia- 1 (DISC-1): Mutant truncation prevents binding to NudE-like (NUDEL) and inhibits neurite outgrowth. Proc. Natl Acad. Sci. USA 2003; 100: 289-294.
80. Sachs NA, Sawa A, Holmes SE, Ross CA, DeLisi LE, Margolis RL. A frameshift mutation in Disrupted in Schizophrenia 1 in an American family with schizophrenia and schizoaffective disorder. Mol. Psychiatry 2005; 10: 758-764.
81. Green EK, Norton N, Peirce T et al. Evidence that a DISC1 frame-shift deletion associated with psychosis in a single family may not be a pathogenic mutation. Mol. Psychiatry 2006; 11: 798-799.
82. Hayden EP, Nurnberger JI Jr. Molecular genetics of bipolar disorder. Genes Brain Behav. 2006; 5: 85-95.
83. Schosser A, Fuchs K, Leisch F et al. Possible linkage of schizophrenia and bipolar affective disorder to chromosome 3q29; a follow-up. J. Psychiatr. Res. 2004; 38: 357-364.
84. Hong KS, McInnes LA, Service SK et al. Genetic mapping using haplotype and model-free linkage analysis supports previous evidence for a locus predisposing to severe bipolar disorder at 5q31-33. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2004; 125: 83-86.
85. Shink E, Harvey M, Tremblay M et al. Analysis of microsatellite markers and single nucleotide polymorphisms in candidate genes for susceptibility to bipolar affective disorder in the chromosome 12Q24.31 region. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2005; 135: 50-58.
86. Shink E, Harvey M, Tremblay M et al. Exclusion of nonsynonymous SNPs and a polyglutamine tract in SMRT/N-CoR2 as common deleterious mutation for bipolar disorder in the Sagnenay-Lac-St-Jean population. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2005; 134: 10-12.
87. Blair IP, Badenhop RF, Scimone A et al. Association analysis of transcripts from the bipolar susceptibility locus on chromosome 4q35, exclusion of a pathogenic role for eight positional candidate genes. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2005; 134: 56-59.
88. Blair IP, Badenhop RF, Scimone A et al. Identification, characterization, and association analysis of novel genes from the bipolar disorder susceptibility locus on chromosome 4q35. Psychiatr. Genet. 2005; 15: 199-204.
89. Kato T, Kato N. Mitochondrial dysfunction in bipolar disorder. Bipolar Disord. 2000; 2: 180-190.
90. Burnett BB, Gardner A, Boles RG. Mitochondrial inheritance in depression, dysmotility and migraine? J. Affect. Disord. 2005; 88: 109-116.
91. Boles RG, Burnett BB, Gleditsch K et al. A high predisposition to depression and anxiety in mothers and other matrilineal relatives of children with presumed maternally inherited mitochondrial disorders. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2005; 137: 20-24.
92. Kasahara T, Kubota M, Miyauchi T et al. Mice with neuron-specific accumulation of mitochondrial DNA mutations show mood disorder-like phenotypes. Mol. Psychiatry 2006; 11: 523, 577-593.
93. Green E, Elvidge G, Jacobsen N et al. Localization of bipolar susceptibility locus by molecular genetic analysis of the chromosome 12q23-q24 region in two pedigrees with bipolar disorder and Darier's disease. Am. J. Psychiatry 2005; 162: 35-42.
94. Kimmel RJ, Kovacs I, Vrabel C, Wood B, Schalling M, Kelsoe JR. Cosegregation of bipolar disorder and autosomal-dominant medullary cystic kidney disease in a large family. Am. J. Psychiatry 2005; 162: 1972-1974.
95. Middleton FA, Pato CN, Gentile KL et al. Gene expression analysis of peripheral blood leukocytes from discordant sib-pairs with schizophrenia and bipolar disorder reveals points of convergence between genetic and functional genomic approaches. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2005; 136: 12-25.
96. Iwamoto K, Kakiuchi C, Bundo M, Ikeda K, Kato T. Molecular characterization of bipolar disorder by comparing gene expression profiles of postmortem brains of major mental disorders. Mol. Psychiatry 2004; 9: 406-416.
97. Iwamoto K, Bundo M, Washizuka S, Kakiuchi C, Kato T. Expression of HSPF1 and LIM in the lymphoblastoid cells derived from patients with bipolar disorder and schizophrenia. J. Hum. Genet. 2004; 49: 227-231.
98. Iga J, Ueno S, Yamauchi K et al. Gene expression and association analysis of LIM (PDLIM5) in major depression. Neurosci. Lett. 2006; 400: 203-207.
99. Horiuchi Y, Arai M, Niizato K et al. A polymorphism in the PDLIM5 gene associated with gene expression and schizophrenia. Biol. Psychiatry 2006; 59: 434-439.
100. Washizuka S, Iwamoto K, Kazuno AA et al. Association of mitochondrial complex I subunit gene NDUFV2 at 18p11 with bipolar disorder in Japanese and the National Institute of Mental Health pedigrees. Biol. Psychiatry 2004; 56: 483-489.
101. Kakiuchi C, Iwamoto K, Ishiwata M et al. Impaired feedback regulation of XBP1 as a genetic risk factor for bipolar disorder. Nat. Genet. 2003; 35: 171-175.
102. Kakiuchi C, Ishiwata M, Hayashi A, Kato T. XBP1 induces WFS1 through an endoplasmic reticulum stress response element-like motif in SH-SY5Y cells. J. Neurochem. 2006; 97: 545-555.
103. Kato T, Iwamoto K, Washizuka S et al. No association of mutations and mRNA expression of WFS1/wolframin with bipolar disorder in humans. Neurosci. Lett. 2003; 338: 21-24.
104. Ni X, Trakalo JM, Mundo E et al. Linkage disequilibrium between dopamine D1 receptor gene (DRD1) and bipolar disorder. Biol. Psychiatry 2002; 52: 1144-1150.
105. Tsutsumi T, Holmes SE, McInnis MG et al. Novel CAG/CTG repeat expansion mutations do not contribute to the genetic risk for most cases of bipolar disorder or schizophrenia. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2004; 124: 15-19.
106. Mansour HA, Monk TH, Nimgaonkar VL. Circadian genes and bipolar disorder. Ann. Med. 2005; 37: 196-205.
107. Cheng R, Juo SH, Loth JE et al. Genome-wide linkage scan in a large bipolar disorder sample from the National Institute of Mental Health genetics initiative suggests putative loci for bipolar disorder, psychosis, suicide, and panic disorder. Mol. Psychiatry 2006; 11: 252-260.
108. Venken T, Claes S, Sluijs S et al. Genomewide scan for affective disorder susceptibility loci in families of a northern Swedish isolated population. Am. J. Hum. Genet. 2005; 76: 237-248.
109. Shink E, Morissette J, Sherrington R, Barden N. A genome-wide scan points to a susceptibility locus for bipolar disorder on chromosome 12. Mol. Psychiatry 2005; 10: 545-552.
110. Schumacher J, Kaneva R, Jamra RA et al. Genomewide scan and fine-mapping linkage studies in four European samples with bipolar affective disorder suggest a new susceptibility locus on chromosome 1p35-p36 and provides further evidence of loci on chromosome 4q31 and 6q24. Am. J. Hum. Genet. 2005; 77: 1102-1111.
111. McQueen MB, Devlin B, Faraone SV et al. Combined analysis from eleven linkage studies of bipolar disorder provides strong evidence of susceptibility loci on chromosomes 6q and 8q. Am. J. Hum. Genet. 2005; 77: 582-595.
112. Lambert D, Middle F, Hamshere ML et al. Stage 2 of the Wellcome Trust UK-Irish bipolar affective disorder sibling-pair genome screen: Evidence for linkage on chromosomes 6q16-q21, 4q12-q21, 9p21, 10p14-p12 and 18q22. Mol. Psychiatry 2005; 10: 831-841.
113. Macgregor S, Visscher PM, Knott SA et al. A genome scan and follow-up study identify a bipolar disorder susceptibility locus on chromosome 1q42. Mol. Psychiatry 2004; 9: 1083-1090.
114. Pato CN, Middleton FA, Gentile KL et al. Genetic linkage of bipolar disorder to chromosome 6q22 is a consistent finding in Portuguese subpopulations and may generalize to broader populations. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2005; 134: 119-121.
115. Fallin MD, Lasseter VK, Wolyniec PS et al. Genomewide linkage scan for bipolar-disorder susceptibility loci among Ashkenazi Jewish families. Am. J. Hum. Genet. 2004; 75: 204-219.
116. Park N, Juo SH, Cheng R. et al. Linkage analysis of psychosis in bipolar pedigrees suggests novel putative loci for bipolar disorder and shared susceptibility with schizophrenia. Mol. Psychiatry 2004; 9: 1091-1099.
117. Sklar P, Pato MT, Kirby A et al. Genome-wide scan in Portuguese Island families identifies 5q31-5q35 as a susceptibility locus for schizophrenia and psychosis. Mol. Psychiatry 2004; 9: 213-218.
118. Faraone SV, Lasky-Su J, Glatt SJ, Van Eerdewegh P, Tsuang MT. Early onset bipolar disorder: Possible linkage to chromosome 9q34. Bipolar Disord. 2006; 8: 144-151.
119. Lin PI, McInnis MG, Potash JB et al. Assessment of the effect of age at onset on linkage to bipolar disorder: Evidence on chromosomes 18p and 21q. Am. J. Hum. Genet. 2005; 77: 545-555.
120. Faraone SV, Glatt SJ, Su J, Tsuang MT. Three potential susceptibility loci shown by a genome-wide scan for regions influencing the age at onset of mania. Am. J. Psychiatry 2004; 161: 625-630.
121. Maziade M, Roy MA, Chagnon YC et al. Shared and specific susceptibility loci for schizophrenia and bipolar disorder: A dense genome scan in Eastern Quebec families. Mol. Psychiatry 2005; 10: 486-499.
122. Als TD, Dahl HA, Flint TJ et al. Possible evidence for a common risk locus for bipolar affective disorder and schizophrenia on chromosome 4p16 in patients from the Faroe Islands. Mol. Psychiatry 2004; 9: 93-98.
123. Visscher PM, Haley CS, Ewald H et al. Joint multi-population analysis for genetic linkage of bipolar disorder or 'wellness' to chromosome 4p. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2005; 133: 18-24.
124. Geller B, Badner JA, Tillman R, Christian SL, Bolhofner K, Cook EH Jr. Linkage disequilibrium of the brain-derived neurotrophic factor Val66Met polymorphism in children with a prepubertal and early adolescent bipolar disorder phenotype. Am. J. Psychiatry 2004; 161: 1698-1700.
125. Masoliver E, Menoyo A, Perez V et al. Serotonin transporter linked promoter (polymorphism) in the serotonin transporter gene may be associated with antidepressant-induced mania in bipolar disorder. Psychiatr. Genet. 2006; 16: 25-29.
126. Serretti A, Mandelli L, Lorenzi C et al. Temperament and character in mood disorders: Influence of DRD4, SERTPR, TPH and MAO-A polymorphisms. Neuropsychobiology 2006; 53: 9-16.
127. Serretti A, Cusin C, Benedetti F et al. Insomnia improvement during antidepressant treatment and CLOCK gene polymorphism. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2005; 137: 36-39.
128. Schulze TG, Buervenich S, Badner JA et al. Loci on chromosomes 6q and 6p interact to increase susceptibility to bipolar affective disorder in the national institute of mental health genetics initiative pedigrees. Biol. Psychiatry 2004; 56: 18-23.
129. McDonald C, Bullmore ET, Sham PC et al. Association of genetic risks for schizophrenia and bipolar disorder with specific and generic brain structural endophenotypes. Arch. Gen. Psychiatry 2004; 61: 974-984.
130. Rybakowski JK, Borkowska A, Skibinska M et al. Prefrontal cognition in schizophrenia and bipolar illness in relation to Val66Met polymorphism of the brain-derived neurotrophic factor gene. Psychiatry Clin. Neurosci. 2006; 60: 70-76.
131. Massat I, Souery D, Del-Favero J et al. Association between COMT (Val158Met) functional polymorphism and early onset in patients with major depressive disorder in a European multicenter genetic association study. Mol. Psychiatry 2005; 10: 598-605.
132. McGuffin P, Knight J, Breen G et al. Whole genome linkage scan of recurrent depressive disorder from the depression network study. Hum. Mol. Genet. 2005; 14: 3337-3345.
133. Holmans P, Zubenko GS, Crowe RR et al. Genomewide significant linkage to recurrent, early-onset major depressive disorder on chromosome 15q. Am. J. Hum. Genet. 2004; 74: 1154-1167.
134. Camp NJ, Lowry MR, Richards RL et al. Genome-wide linkage analyses of extended Utah pedigrees identifies loci that influence recurrent, early-onset major depression and anxiety disorders. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2005; 135: 85-93.
135. Sequeira A, Gwadry FG, Ffrench-Mullen JM et al. Implication of SSAT by gene expression and genetic variation in suicide and major depression. Arch. Gen. Psychiatry 2006; 63: 35-48.
136. Caspi A, Sugden K, Moffitt TE et al. Influence of life stress on depression: Moderation by a polymorphism in the 5-HTT gene. Science 2003; 301: 386-389.
137. Kaufman J, Yang BZ, Douglas-Palumberi H et al. Social supports and serotonin transporter gene moderate depression in maltreated children. Proc. Natl Acad. Sci. USA 2004; 101: 17 316-17 321.
138. Eley TC, Sugden K, Corsico A et al. Gene-environment interaction analysis of serotonin system markers with adolescent depression. Mol. Psychiatry 2004; 9: 908-915.
139. Sjoberg RL, Nilsson KW, Nordquist N et al. Development of depression: Sex and the interaction between environment and a promoter polymorphism of the serotonin transporter gene. Int. J. Neuropsychopharmacol. 2006; 9: 443-449.
140. Kaufman J, Yang BZ, Douglas-Palumberi H et al. Brain-derived neurotrophic factor-5-HTTLPR gene interactions and environmental modifiers of depression in children. Biol. Psychiatry 2006; 59: 673-680.
141. Barr CS, Newman TK, Schwandt M et al. Sexual dichotomy of an interaction between early adversity and the serotonin transporter gene promoter variant in rhesus macaques. Proc. Natl Acad. Sci. USA 2004; 101: 12 358-12 363.
142. Surtees PG, Wainwright NW, Willis-Owen SA et al. No association between the BDNF Val66Met polymorphism and mood status in a non-clinical community sample of 7389 older adults. J. Psychiatr. Res. 2006; [epub ahead of print].
143. Gillespie NA, Whitfield JB, Williams B, Heath AC, Martin NG. The relationship between stressful life events, the serotonin transporter (5-HTTLPR) genotype and major depression. Psychol Med. 2005; 35: 101-111.
144. Surtees PG, Wainwright NW, Willis-Owen SA, Luben R, Day NE, Flint J. Social adversity, the serotonin transporter (5-HTTLPR) polymorphism and major depressive disorder. Biol. Psychiatry 2006; 59: 224-229.
145. Egan MF, Kojima M, Callicott JH et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003; 112: 257-269.
146. Oswald P, Del-Favero J, Massat I et al. No implication of brain-derived neurotrophic factor (BDNF) gene in unipolar affective disorder: Evidence from Belgian first and replication patient-control studies. Eur. Neuropsychopharmacol. 2005; 15: 491-495.
147. Zhang X, Gainetdinov RR, Beaulieu JM et al. Loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression. Neuron 2005; 45: 11-16.
148. Zhou Z, Peters EJ, Hamilton SP et al. Response to Zhang et al. (2005): Loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression. Neuron 45, 11-16. Neuron 2005; 48: 702-703; 705-706.
149. Van Den Bogaert A, De Zutter S, Heyrman L et al. Response to Zhang et al (2005): Loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major Depression. Neuron 45, 11-16. Neuron 2005; 48: 704; 705-706.
150. Glatt CE, Carlson E, Taylor TR, Risch N, Reus VI, Schaefer CA. Response to Zhang et al. (2005): Loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression. Neuron 45, 11-16. Neuron 2005; 48: 704-705; 705-706.
151. Garriock HA, Allen JJ, Delgado P et al. Lack of association of TPH2 exon XI polymorphisms with major depression and treatment resistance. Mol. Psychiatry 2005; 10: 976-977.
152. Delorme R, Durand CM, Betancur C et al. No human tryptophan hydroxylase-2 gene R441H mutation in a large cohort of psychiatric patients and control subjects. Biol. Psychiatry 2006; 60: 202-203.
153. De Luca V, Mueller DJ, Tharmalingam S, King N, Kennedy JL. Analysis of the novel TPH2 gene in bipolar disorder and suicidality. Mol. Psychiatry 2004; 9: 896-897.
154. De Luca V, Hlousek D, Likhodi O, Van Tol HH, Kennedy JL, Wong AH. The interaction between TPH2 promoter haplotypes and clinical-demographic risk factors in suicide victims with major psychoses. Genes Brain Behav. 2006; 5: 107-110.
155. Ikeda A, Kato T. Biological predictors of lithium response in bipolar disorder. Psychiatry Clin. Neurosci. 2003; 57: 243-250.
156. Serretti A, Cusin C, Rossini D, Artioli P, Dotoli D, Zanardi R. Further evidence of a combined effect of SERTPR and TPH on SSRIs response in mood disorders. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2004; 129: 36-40.
157. Rybakowski JK, Suwalska A, Czerski PM, Dmitrzak-Weglarz M, Leszczynska-Rodziewicz A, Hauser J. Prophylactic effect of lithium in bipolar affective illness may be related to serotonin transporter genotype. Pharmacol. Rep. 2005; 57: 124-127.
158. Rybakowski JK, Suwalska A, Skibinska M et al. Prophylactic lithium response and polymorphism of the brain-derived neurotrophic factor gene. Pharmacopsychiatry 2005; 38: 166-170.
159. Masui T, Hashimoto R, Kusumi I et al. Lithium response and Val66Met polymorphism of the brain-derived neurotrophic factor gene in Japanese patients with bipolar disorder. Psychiatr. Genet. 2006; 16: 49-50.
160. Michelon L, Meira-Lima I, Cordeiro Q et al. Association study of the INPP1, 5HTT, BDNF, AP-2beta and GSK-3beta GENE variants and retrospectively scored response to lithium prophylaxis in bipolar disorder. Neurosci. Lett. 2006; 403: 288-293.
161. Kakiuchi C, Kato T. Lithium response and -116C/G polymorphism of XBP1 in Japanese patients with bipolar disorder. Int. J. Neuropsychopharmacol. 2005; 8: 631-632.
162. Masui T, Hashimoto R, Kusumi I et al. A possible association between the -116C/G single nucleotide polymorphism of the XBP1 gene and lithium prophylaxis in bipolar disorder. Int. J. Neuropsychopharmacol. 2006; 9: 83-88.
163. Kirchheiner J, Nickchen K, Sasse J, Bauer M, Roots I, Brockmoller J. A 40-basepair VNTR polymorphism in the dopamine transporter (DAT1) gene and the rapid response to antidepressant treatment. Pharmacogenomics J. 2006; [epub ahead of print].
164. Kraft JB, Slager SL, McGrath PJ, Hamilton SP. Sequence analysis of the serotonin transporter and associations with antidepressant response. Biol. Psychiatry 2005; 58: 374-381.
165. Lee HJ, Cha JH, Ham BJ et al. Association between a G-protein beta 3 subunit gene polymorphism and the symptomatology and treatment responses of major depressive disorders. Pharmacogenomics J. 2004; 4: 29-33.
166. Binder EB, Salyakina D, Lichtner P et al. Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nat. Genet. 2004; 36: 1319-1325.
167. van Rossum EF, Binder EB, Majer M et al. Polymorphisms of the glucocorticoid receptor gene and major depression. Biol. Psychiatry 2006; 59: 681-688.
168. McMahon FJ, Buervenich S, Charney D et al. Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment. Am. J. Hum. Genet. 2006; 78: 804-814.
169. Chagnon YC, Merette C, Bouchard RH, Emond C, Roy MA, Maziade M. A genome wide linkage study of obesity as secondary effect of antipsychotics in multigenerational families of eastern Quebec affected by psychoses. Mol. Psychiatry 2004; 9: 1067-1074.
170. Suzuki Y, Sawamura K, Someya T. Polymorphisms in the 5-hydroxytryptamine 2A receptor and CytochromeP4502D6 genes synergistically predict fluvoxamine-induced side effects in Japanese depressed patients. Neuropsychopharmacology 2006; 31: 825-831.
171. Chung WH, Hung SI, Hong HS et al. Medical genetics: A marker for Stevens-Johnson syndrome. Nature 2004; 428: 486.
172. Alfirevic A, Mills T, Harrington P et al. Serious carbamazepine-induced hypersensitivity reactions associated with the HSP70 gene cluster. Pharmacogenet. Genomics 2006; 16: 287-296.
173. Middleton FA, Pato MT, Gentile KL et al. Genome-wide linkage analysis of bipolar disorder by use of a high-density single-nucleotide- polymorphism (SNP) genotyping assay: A comparison with microsatellite marker assays and finding of significant linkage to chromosome 6q22. Am. J. Hum. Genet. 2004; 74: 886-897.
174. Ewald H, Wikman FP, Teruel BM et al. A genome-wide search for risk genes using homozygosity mapping and microarrays with 1494 single-nucleotide polymorphisms in 22 eastern Cuban families with bipolar disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2005; 133: 25-30.
175. Wilson GM, Flibotte S, Chopra V, Melnyk BL, Honer WG, Holt RA. DNA copy-number analysis in bipolar disorder and schizophrenia reveals aberrations in genes involved in glutamate signaling. Hum. Mol. Genet. 2006; 15: 743-749.
176. Okada T, Hashimoto R, Numakawa T et al. A complex polymorphic region in the brain-derived neurotrophic factor (BDNF) gene confers susceptibility to bipolar disorder and affects transcriptional activity. Mol. Psychiatry 2006; 11: 695-703.
177. Nakamura M, Ueno S, Sano A, Tanabe H. The human serotonin transporter gene linked polymorphism (5-HTTLPR) shows ten novel allelic variants. Mol. Psychiatry 2000; 5: 32-38.
178. Sakai K, Nakamura M, Ueno S et al. The silencer activity of the novel human serotonin transporter linked polymorphic regions. Neurosci. Lett. 2002; 327: 13-16.
179. Hu XZ, Lipsky RH, Zhu G et al. Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. Am. J. Hum. Genet. 2006; 78: 815-826.
180. Newton-Cheh C, Hirschhorn JN. Genetic association studies of complex traits: Design and analysis issues. Mutat. Res. 2005; 573: 54-69.
181. Freimer NB, Sabatti C. Guidelines for association studies in human molecular genetics. Hum. Mol. Genet. 2005; 14: 2481-2483.
182. Anonymous. Framework for a fully powered risk engine. Nat. Genet. 2005; 37: 1153.
183. Ioannidis JP, Gwinn M, Little J et al. A road map for efficient and reliable human genome epidemiology. Nat. Genet. 2006; 38: 3-5.
184. Iwamoto K, Kato T. Molecular profiling of schizophrenia and related mental disorders. Neuroscientist 2006; 12: 349-361.
185. Kato T, Iwamoto K, Kakiuchi C, Kuratomi G, Okazaki Y. Genetic or epigenetic difference causing discordance between monozygotic twins as a clue to molecular basis of mental disorders. Mol. Psychiatry 2005; 10: 622-630.